|
QLK3-1999-00020 |
Mesodermal stem cells: from basic biology to development of pre-clinical models of tissue replacement and cell therapy |
|
QLK3-1999-00064 |
Antigen presentation by chaperon proteins and CD4+ T cell specific help for a new efficient strategy of cancer vaccination |
|
QLK3-1999-00095 |
Glycosylation engineering for novel antibiotics |
|
QLK3-1999-00099 |
The c-Ret receptor tyrosine kinase as a target for drug discovery |
|
QLK3-1999-00217 |
Development of a cancer vaccine: Combining DNA and specific glycoprotein/glycopeptide formulation of a tumour antigen |
|
QLK3-1999-00241 |
Thematic network around cystic fibrosis and related diseases |
|
QLK3-1999-00364 |
Targeted vectors for cancer gene therapy: receptor and tran-scriptional targeting of retroviral, lentiviral, and adenoviral vectors |
|
QLK3-1999-00380 |
Cord blood as an allogeneic source of stem cell for clinical use |
|
QLK3-1999-00435 |
Electronic noses for non-invasive quality, safety and in-process control of industrial animal cell culture processes |
|
QLK3-1999-00484 |
Cliniporator: a new adaptive generator for DNA electrotransfer in vivo for gene therapy |
|
QLK3-1999-00531 |
Development of high-throughput PNA-based molecular diagnostic systems |
|
QLK3-1999-00536 |
Biologically active novel glycosaminoglycans |
|
QLK3-1999-00559 |
Biomechanical interactions in tissue engineering and surgical repair (BITES) |
|
QLK3-1999-00620 |
Therapeutic recombinant allergens from structural allergology |
|
QLK3-1999-00625 |
Tissue engineered nerve repair devices: development of European medical implantable device and research training focus |
|
QLK3-1999-00650 |
Metabolic engineering of glycopeptide antibiotics: technology, optimisation and production |
|
QLK3-1999-00672 |
Technology for the production of health related substances by marine sponges |
|
QLK3-1999-00692 |
The plastid factory |
|
QLK3-1999-00702 |
Pre-clinical evaluation of delivery systems for neuroprotective gene therapy in neurodegenerative diseases |
|
QLK3-1999-00729 |
Designing and improving health and food related production processes using filamentous fungal cell factories |
|
QLK3-1999-00811 |
Comparison and validation of novel pyrogen tests based on the human fever reaction |
|
QLK3-1999-00859 |
Lentiviral vectors for gene therapy of the hematopoietic system: deve-lop-ment from bench to bedside |
|
QLK3-1999-00875 |
Identification, lead generation, structural biology and validation of targets for cancer therapy: an integrated methodological approach |
|
QLK3-1999-00894 |
European cell therapy in the nervous system (ECTINS) |
|
QLK3-1999-01067 |
Therapeutic strategies for boron neutron capture therapy (BNCT) |
|
QLK3-1999-01262 |
Genetic programming of human cell factories for the specific treatment of cancer and viral infection |
|
QLK3-2000-00076 |
Suppression of programmed cell death in industrial scale biological production systems |
|
QLK3-2000-00079 |
Screening assays for new bacterial inhibitors based on targets active in septation |
|
QLK3-2000-00084 |
Cellular production of human recombinant collagens, gelatins, laminins and growth factors and their use in vascular grafts and other applications |
|
QLK3-2000-00131 |
Combinatorial biosynthesis: generation of novel therapeutic substances by combining genes from actinomycetes and cyanobacteria |
|
QLK3-2000-00160 |
Evolutionary discovery of novel drugs by orchestration of polymer-supported combinatorial bio-/chemistry (COMBIOCAT) |
|
QLK3-2000-00204 |
From conopeptide scaffolds to analgesic leads |
|
QLK3-2000-00237 |
Functional characterisation of orphan G protein-coupled receptors and their validation as drug targets |
|
QLK3-2000-00270 |
Human cell systems for predicting the allergenicity of genetically engineered proteins |
|
QLK3-2000-00340 |
Oral delivery of vaccine and therapeutic products using non-pathogenic lactic acid bacteria |
|
QLK3-2000-00513 |
Towards new antibiotics |
|
QLK3-2000-00634 |
Therapeutic Oligomers for in vivo targeted gene modification |
|
QLK3-2000-00721 |
New systems of controlled gene expression for improved delivery of therapeutic substances |
|
QLK3-2000-00778 |
Aquaporin blockers for novel skin care products and diuretics |
|
QLK3-2000-00785 |
The B-cell line DT40 as a genetic model and a substitute for animal research |
|
QLK3-2001-00987 |
New drugs and treatment strategies of urinary incontinence and voiding disorders |
|
QLK3-2001-01010 |
Targeted autonomous parvoviruses as anti-cancer tools to deliver immunostimulating molecules and activate cellular responses against tumours |
|
QLK3-2001-01074 |
Cardiovascular angiography with digital imaging detectors. low doses diagnostic system for in vivo cardiological imaging (CANDID) |
|
QLK3-2001-01169 |
Platelet diagnostics |
|
QLK3-2001-01265 |
Suicide gene therapy in stem cell transplantation (SGT in SCT) |
|
QLK3-2001-01275 |
Cellular production of Wnts, secreted growth and differentiation factors and their use as coordinators of organ specific stem cells |
|
QLK3-2001-01318 |
Detection of early markers in mammography (Dear-Mama) |
|
QLK3-2001-01495 |
Engineering human antibody derivatives, which specifically recognise and ablate new blood vessels, for the therapy of angiogenesis-related pathologies |
|
QLK3-2001-01737 |
Clostridial-directed enzyme prodrug therapy (CDEPT): a novel approach to cancer treatment |
|
QLK3-2001-01889 |
Development and clinical study of a bioartificial liver based on reversibly immortalised human hepatocytes |
|
QLK3-2001-01976 |
A proteomics and structural genomics approach to therapeutic targeting of glycosaminoglycan-binding proteins |
|
QLK3-2001-02120 |
Development of human dopaminergic neuronal cell lines for transplantation (DANCE) |
|
QLK3-2001-02226 |
Biodegradable controlled drug delivery systems for the treatment of brain diseases |
|
QLK3-2001-02345 |
Development of a rapid high-throughput assay for sensitive and specific detection and strain typing of Creutzfeldt-Jakob disease based on fluorescence correlation spectroscopy (FCS PRION TYPING) |
|
QLK3-2001-02362 |
Early diagnosis of Alzheimer’s disease and related dementia (DIADEM) |
|
QLK3-2001-02458 |
A systematic and multidisciplinary approach towards understanding and therapy of the inborn lysosomal storage disease alpha-mannosidosis |
|
QLK3-1999-00004 |
Enhanced, intelligent processing of food and related wastes using thermo-philic populations (INTELLTHERMCONTROL) |
|
QLK3-1999-00041 |
Strategies to accelerate the productive biodegradation of several herbicides under environmental stress conditions (HERBIC BIOREM) |
|
QLK3-1999-00080 |
Novel bioprocesses for hemicellulose up-grading (BIO-HUG) |
|
QLK3-1999-00097 |
The use of mycorrhizal fungi in phytoremediation projects (MYCOREM) |
|
QLK3-1999-00326 |
Use of bioavailability promoting organisms to decontaminate PAH-polluted soils: Preparation towards large scale field exploitation (BIOSTIMUL) |
|
QLK3-1999-00590 |
Fungal metalloenzymes oxidizing aromatic compounds of industrial interest (PELAS) |
|
QLK3-1999-01213 |
Novel remediation technology for vaccine production effluents containing organomercurials (ORGANOMERCURIALS) |
|
QLK3-2000-00060 |
An ecologically safe selection system for transgenic crops based on modified plant-tubulin genes (ECOTUB) |
|
QLK3-2000-00163 |
Multifunctional permeable barriers carrying well-performing microbial biofilms for treatment of mixed pollutant plumes (MULTIBARRIER) |
|
QLK3-2000-00164 |
Endophytic degrader bacteria for improving phytoremediation of organic xenobiotics (ENDEGRADE) |
|
QLK3-2000-00170 |
Exploring genomics to engineer an environmentally friendly microorganismfor bioremediation purposes (MIFRIEND) |
|
QLK3-2000-00361 |
Virus-resistant transgenic plants: Ecological impact of gene flow (VRTP IMPACT) |
|
QLK3-2000-00426 |
Engineering integrated biocatalysts for the production of chiral epoxides and other pharmaceutical intermediates (EPOX) |
|
QLK3-2000-00479 |
An integrated approach towards removal by plants of toxic metals from polluted soils (METALLOPHYTES) |
|
QLK3-2000-00481 |
Sensor arrays for environmental, generic and routine detection of pesticides (SAFEGUARD) |
|
QLK3-2000-00547 |
Effects and mechanisms of Bt transgenes on biodiversity of non-target insects: pollinators, herbivores and their natural enemies (Bt-BIONOTA) |
|
QLK3-2000-00607 |
Biological microanalysis of bacterial pollution for real time analysis of surfaces (BIO4SURE) |
|
QLK3-2000-00650 |
New biosensors for improved detection of environmental contamination by anticholinesterase pesticides (ACHEB) |
|
QLK3-2000-00731 |
Adaptation of microbial communities to organic contaminants in oligotrophics aquifers (AMICO) |
|
QLK3-2000-01311 |
Evaluation/validation of novel biosensors in real environmental and food samples (VALIDATION OF BIOSENSORS) |
|
QLK3-2000-01481 |
Intelligent signal processing of biosensor array using pattern recognition forcharacterisation of wastewater: aiming towards alarm systems (INTELLISENS) |
|
QLK3-2000-01528 |
Biodiversity of methanotrophs and their bioremediation and biotechnological exploitation (BOMBBE) |
|
QLK3-2000-01598 |
Impact of three selected biotechnological strategies for potato pathogen control on the indigenous soil microbiota (POTATOCONTROL) |
|
QLK3-2000-01759 |
Ecological and environmental biosafety assessment of novel plant and microbial biotechnology products (ECO-SAFE) |
|
QLK3-2001-01473 |
Expression profiles as fingerprints for the safety evaluation of new strains, including GMOs used in bioprocessed food (EXPRESS-FINGERPRINTS) |
|
QLK3-2001-01629 |
Assembly and application of Photosystem II-based biosensors for large scale environmental screening of specific herbicides and heavy metals (BEEP) |
|
QLK3-2001-01657 |
Analysis of geneflow from crop to wild forms in lettuce and chicory and its population-ecological consequences in the context of GM-crop biosafety (ANGEL) |
|
QLK3-2001-02242 |
Gene flow from transgenic plants: evaluation and biotechnology (TRANSBAC) |
|
QLK3-2001-02295 |
Dynamics and composition of filamentous microorganism communities in industrial water systems (DYNAFILM) |
|
QLK3-1999-00034 |
Polysaccharide molecular engineering – The use of mannuronan C-5 epimerases for the upgrading of alginates and heteromannuronans (POLYENG) |
|
QLK3-1999-00089 |
Upgrading of sugar beet pectins by enzymatic modification and molecular farming |
|
QLK3-1999-00104 |
In vitro production of high quality mammalian oocytes for biotechnology, assisted reproduction, breeding and toxicology-teratology purposes |
|
QLK3-1999-00213 |
Controlling fatty acid breakdown in order to produce viable oilseeds with increased yields of novel oils (CONSAB) |
|
QLK3-1999-00386 |
Molecular evolution of protease substrates involved in carcinogenesis by in vivo selection of retroviral display libraries |
|
QLK3-1999-00413 |
Engineering of cellular quality control systems in Bacillus subtilis for the production of high value-added proteins |
|
QLK3-1999-00533 |
Electric DNA chips for bioprocess control |
|
QLK3-1999-00917 |
Exploitation of a novel sec-independent secretion pathway for protein production |
|
QLK3-2000-00020 |
A functional blueprint for the Zea mays endosperm cell factory |
|
QLK3-2000-00078 |
Improvement of transgene expression and gene silencing in transgenic plants |
|
QLK3-2000-00082 |
The targeting and biosynthesis of membrane and secretory proteins |
|
QLK3-2000-00103 |
Optimising nutritional quality of crops |
|
QLK3-2000-00122 |
Exploitation of Streptomyces protein secretion for robust biopharmaceutical bioprocess development |
|
QLK3-2000-00174 |
Applications of nanobiotechnologies to yeast: optimisation of bioprocesses for products of industrial, medical, and agricultural importance |
|
QLK3-2000-00196 |
Changing maize grain development to provide lines better adapted to the European agricultural and commercial environment |
|
QLK3-2000-00227 |
The dynamic nature of introgressive hybridisation in natural and introduced polyploid plants from agricultural and riparian landscapes: An evaluation of molecular tools in willows |
|
QLK3-2000-00273 |
Engineering of hybrid proteins containing cellulose-binding domains – Novel biotechnological tools for pulp, paper and textile industry |
|
QLK3-2000-00302 |
Precise and efficient genetic improvement of cereal seeds |
|
QLK3-2000-00328 |
Transcription factors controlling plant responses to environmental stress conditions |
|
QLK3-2000-00349 |
Rational engineering of lipid metabolism in flax to produce branched-chainfatty acids, unusual fatty acids with potent biolubricant properties |
|
QLK3-2000-00362 |
The potential and application of virus host evasion genes that modifyapoptosis and cytokine responses |
|
QLK3-2000-00365 |
Precision engineering of plant genes |
|
QLK3-2000-00463 |
New anti-inflammatory natural products from medicinal plants using inducible transcription factors and their signalling pathways as molecular targets |
|
QLK3-2000-00497 |
Construction of Corynebacterium glutamicum strains producing either L-valine or D-pantothenic acid – A rational approach using genome research |
|
QLK3-2000-00640 |
Exploiting new solutes from hyperthermophiles for the preservation of biomaterials: cell factories for production of hypersolutes |
|
QLK3-2000-00649 |
The European Sulfolobus Project. Screening for and expressing thermostable enzymes of industrial interest from Sulfolobus and other Crenarchaeotes |
|
QLK3-2000-00720 |
Exploiting the HSP70 chaperone machine for novel therapeutic strategies in human diseases and for the engineering of productivecellular biomolecular factories |
|
QLK3-2000-00725 |
Industrial biocatalysis with new oxygenases in a novel electro-enzyme reactor |
|
QLK3-2000-00809 |
PROduction of high value-added carotenoids and proVITamin A in cell factory crops (ProVitA) |
|
QLK3-2000-00924 |
Exploiting synthetic SH2-scaffolded receptoire libraries to profile cancer cells and to interfere with cancer-related phenotypes |
|
QLK3-2000-01038 |
Disease insights from single cell signaling |
|
QLK3-2000-01068 |
Genetic prospecting of biodiversity in geothermal habitats |
|
QLK3-2000-01079 |
The European Wolbachia project: towards novel biotechnological approaches for control of arthropod pests and modification of beneficial arthropod species by endosymbiotic bacteria |
|
QLK3-2000-01500 |
Nanobiotechnology and medicine (Nanomed) |
|
QLK3-2000-01537 |
Exploiting yeast cell wall for high throughput screening of antimicrobial agents |
|
QLK3-2000-01678 |
Exploration of genomic and metabolite diversity of a novel group of abundant soil bacteria |
|
QLK3-2001-01586 |
Novel bioinsecticides fom insect parasitoids |
|
QLK3-2001-01676 |
Novel bioreductions by hyperthermophilic microorganisms for the natural, specific and on-line production of fine chemicals |
|
QLK3-2001-01783 |
Novel sources of actinomycete diversity for detection of antimicrobial agents with pharmaceutical applications |
|
QLK3-2001-01890 |
Use of simple embryos to search for unknown genes controlling cell proliferation and death |
|
QLK3-2001-02400 |
New products from starch-derived 1,5-Anhydro-D-Fructose (NEPSA) |
